Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
YMABCompany Name
Y-MABS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQY-MABS THERAPEUTICS INC's capexcoverage vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Benchmarks
Similar metrics to CF - Operations:
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
- Capital Expenditure - [Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
- Capital Expenditures Margin - [Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
- Free Cash Flow to Operating Cash Flow - [Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].
Definition of
Benchmark AnalysisMarket
The chart above depicts the distribution of for companies in the Total Stock Market. The average of the companies is 4.42 with a standard deviation of 4.02.
The following table provides additional summary stats:
undefined in the Market:
| filtered constituents | 2.21K |
|---|---|
| min | 0.01 |
| max | 17.91 |
| average | 4.42 |
| median | 3.01 |
| std | 4.02 |